Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
Trial details
- Registry ID
- NCT07400952
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With KeratoconusNCT07400952 | Glaukos Corporation | Phase 2 | Recruiting | 2027-04Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |